Cargando…
Anisodamine potently inhibits SARS-CoV-2 infection in vitro and targets its main protease
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) provoked a pandemic of acute respiratory disease, namely coronavirus disease 2019 (COVID-19). Currently, effective drugs for this disease are urgently warranted. Anisodamine is a traditional Chinese medicine that is predicted as a potentia...
Autores principales: | Wei, Wei, Kong, Ni, Liu, Meng-Zhen, Han, Ting, Xu, Jun-Feng, Liu, Chong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9098399/ https://www.ncbi.nlm.nih.gov/pubmed/35636257 http://dx.doi.org/10.1016/j.bbrc.2022.05.024 |
Ejemplares similares
-
Potent and biostable inhibitors of the main protease of SARS-CoV-2
por: Tsuji, Kohei, et al.
Publicado: (2022) -
Repurposing Halicin as a potent covalent inhibitor for the SARS-CoV-2 main protease
por: Yang, Kai S., et al.
Publicado: (2022) -
QSAR and molecular docking studies on designing potent inhibitors of SARS-CoVs main protease
por: Song, Fucheng, et al.
Publicado: (2023) -
Beneficial Effects of Anisodamine in Shock Involved Cholinergic Anti-Inflammatory Pathway
por: Zhao, Ting, et al.
Publicado: (2011) -
Combined Treatment with Anisodamine and Neostigmine Inhibits Joint Inflammation in Collagen‐Induced Arthritis Mice
por: Zhou, Jv‐Xiang, et al.
Publicado: (2014)